WallStreetZenWallStreetZen

NASDAQ: CERO
Cero Therapeutics Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Cero Therapeutics Holdings revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CERO annual revenue was $0.0, with N/A growth year-over-year.

CERO revenue history

Current Revenue
$0.0
Current Earnings
-$14.2M
Current Profit Margin
0%

Be the first to know when CERO announces revenue.

CERO Revenue History By Year

CERO Yearly RevenueCERO RevenueCERO ChangeCERO Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Cero Therapeutics Holdings Revenue FAQ

What was CERO's revenue last quarter?

Cero Therapeutics Holdings (NASDAQ: CERO) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Cero Therapeutics Holdings's revenue was N/A.

What was Cero Therapeutics Holdings's revenue in 2024?

Cero Therapeutics Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Cero Therapeutics Holdings make in a day?

Based on Cero Therapeutics Holdings annual revenue for the past three years, CERO makes an average of $0.00 per day.

What was Cero Therapeutics Holdings's annual revenue growth in the past year?

As of Q3 2025, Cero Therapeutics Holdings's revenue has grown null year over year. Cero Therapeutics Holdings's revenue in the past year totaled $0.00.

How much does Cero Therapeutics Holdings make in a year?

Cero Therapeutics Holdings's revenue by year for the past three years is:
  • Cero Therapeutics Holdings's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Cero Therapeutics Holdings's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Cero Therapeutics Holdings's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.